<p>Severe allergies should be added to the possible side effects of AstraZeneca's coronavirus vaccine after likely links were found to a number of cases in Britain, the EU's drug regulator said on Friday.</p>.<p>The development comes a day after the European Medicines Agency said it was investigating a separate issue of blood clots that prompted Denmark to suspend use of the jab, but said it remained safe to use.</p>.<p>The Amsterdam-based EMA said it had "recommended an update to the product information to include anaphylaxis and hypersensitivity (allergic reactions) as side effects".</p>.<p>"The update is based on a review of 41 reports of possible anaphylaxis seen among around 5 million vaccinations in the United Kingdom," it said in the highlights of the EMA committee that assesses the risk of medications.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/no-reason-to-stop-using-astrazeneca-covid-19-vaccine-who-961207.html" target="_blank">No reason to stop using AstraZeneca Covid-19 vaccine: WHO</a></strong></p>.<p>"After careful review of the data, (the committee) considered that a link to the vaccine was likely in at least some of these cases."</p>.<p>The EMA said however that anaphylaxis, or what it called "severe allergic reactions", was already what it called a "known side effect that may occur, very rarely, with vaccines".</p>.<p>The AstraZeneca vaccine's product information already said that people should be kept under "close observation for at least 15 minutes" after getting the jab in case of allergic reactions.</p>
<p>Severe allergies should be added to the possible side effects of AstraZeneca's coronavirus vaccine after likely links were found to a number of cases in Britain, the EU's drug regulator said on Friday.</p>.<p>The development comes a day after the European Medicines Agency said it was investigating a separate issue of blood clots that prompted Denmark to suspend use of the jab, but said it remained safe to use.</p>.<p>The Amsterdam-based EMA said it had "recommended an update to the product information to include anaphylaxis and hypersensitivity (allergic reactions) as side effects".</p>.<p>"The update is based on a review of 41 reports of possible anaphylaxis seen among around 5 million vaccinations in the United Kingdom," it said in the highlights of the EMA committee that assesses the risk of medications.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/no-reason-to-stop-using-astrazeneca-covid-19-vaccine-who-961207.html" target="_blank">No reason to stop using AstraZeneca Covid-19 vaccine: WHO</a></strong></p>.<p>"After careful review of the data, (the committee) considered that a link to the vaccine was likely in at least some of these cases."</p>.<p>The EMA said however that anaphylaxis, or what it called "severe allergic reactions", was already what it called a "known side effect that may occur, very rarely, with vaccines".</p>.<p>The AstraZeneca vaccine's product information already said that people should be kept under "close observation for at least 15 minutes" after getting the jab in case of allergic reactions.</p>